Ameriprise Financial Inc Sangamo Therapeutics, Inc Transaction History

Ameriprise Financial Inc

$358 Billion
Q1 2024

A detailed history of Ameriprise Financial Inc transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 11,474 shares of SGMO stock, worth $4,130. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,474

Previous 210,238 94.54%

Holding current value

$4,130

Previous $113,000 93.81%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.42 - $1.38 $83,480 - $274,294	-198,764 Reduced 94.54%	11,474 $7,000
Q4 2023 Feb 14, 2024	BUY	$0.3 - $0.63 $38,168 - $80,153	127,228 Added 153.27%	210,238 $113,000
Q3 2023 Nov 14, 2023	BUY	$0.58 - $1.47 $48,145 - $122,024	83,010 New	83,010 $49,000
Q1 2023 May 15, 2023	SELL	$1.66 - $3.67 $70,775 - $156,474	-42,636 Reduced 61.73%	26,437 $46,000
Q4 2022 Feb 14, 2023	SELL	$2.77 - $5.07 $33,539 - $61,387	-12,108 Reduced 14.91%	69,073 $216,000

Q3 2022 Nov 14, 2022	SELL	$4.27 - $6.39 $15,295 - $22,888	-3,582 Reduced 4.23%	81,181 $398,000
Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.21 $65,242 - $123,523	19,891 Added 30.66%	84,763 $351,000
Q1 2022 May 16, 2022	BUY	$5.23 - $7.82 $214 - $320	41 Added 0.06%	64,872 $377,000
Q4 2021 Feb 14, 2022	BUY	$7.29 - $10.97 $274,512 - $413,086	37,656 Added 138.57%	64,831 $486,000
Q3 2021 Nov 15, 2021	SELL	$9.01 - $12.01 $1,838 - $2,450	-204 Reduced 0.75%	27,175 $245,000
Q2 2021 Aug 16, 2021	SELL	$10.17 - $12.64 $473,240 - $588,177	-46,533 Reduced 62.96%	27,379 $328,000
Q1 2021 May 17, 2021	SELL	$10.88 - $17.05 $727,012 - $1.14 Million	-66,821 Reduced 47.48%	73,912 $926,000
Q4 2020 Feb 12, 2021	SELL	$9.23 - $18.18 $531,417 - $1.05 Million	-57,575 Reduced 29.03%	140,733 $2.2 Million
Q3 2020 Nov 16, 2020	BUY	$9.38 - $12.48 $1.57 Million - $2.09 Million	167,607 Added 545.93%	198,308 $1.87 Million
Q2 2020 Aug 14, 2020	BUY	$6.21 - $11.83 $75,333 - $143,509	12,131 Added 65.33%	30,701 $275,000
Q1 2020 May 15, 2020	BUY	$5.05 - $8.85 $93,778 - $164,344	18,570 New	18,570 $119,000
Q2 2018 Aug 14, 2018	SELL	$13.9 - $19.8 $1.77 Million - $2.52 Million	-127,375 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$16.7 - $26.35 $2.13 Million - $3.36 Million	127,375 New	127,375 $2.42 Million

Others Institutions Holding SGMO

# of Institutions

138

Shares Held

100M

Call Options Held

35.5K

Put Options Held

65.8K

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $56.4M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Sangamo Therapeutics, Inc Transaction History